Universal Detection Technology: Universal Detection Technology Working With the US Department of Commerce to Market Its Anthrax
LOS ANGELES, CA--(Marketwire - July 13, 2009) - [ Universal Detection Technology ] ([ www.udetection.com ]) (
UNDT's [ 5-agent Bioterrorism detection kits ] have been extensively used by first responders and private industry throughout the United States. Testing of the kits by the US DOD as well as the United Kingdom military show that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered "white powders." The kits are designed to test for anthrax, botulinum toxin, Ricin, plague (Y. Pestis) and SEBs in as little as 3 minutes.
"[ Qatar ] is one of the strongest economies among the Gulf Cooperation Council countries and is an emerging power in the region. We are positioning ourselves to be a powerful supplier of counter terrorism products in Qatar," said Jacques Tizabi, UNDT's Chief Executive Officer.
To view UNDT's bioterrorism detection kits on the Commercial Service's website please go to:[ http://www.buyusa.gov/qatar/en/70.html?exp_cat=6010&exp_pid=116 ]. For more information please visit our website at [ www.udetection.com ] or
Email us at [ info@udetection.com ].
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit[ www.udetection.com ].
Forward-Looking Statements
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.